Franz-Josef Neumann. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anti-Bacterial Agents/therapeutic useAntibodies, Bacterial/bloodArteriosclerosis/microbiologyArteriosclerosis/mortalityArteriosclerosis/prevention & controlAzithromycin/therapeutic useChlamydophila Infections/complicationsChlamydophila Infections/drug therapyChlamydophila pneumoniaeFollow-Up StudiesHumansMorbidityMyocardial Infarction/drug therapyMyocardial Infarction/mortalityRandomized Controlled Trials as Topic/statistics & numerical dataRecurrenceRoxithromycin/therapeutic useSample SizeTreatment Outcome
Substances： See more » Anti-Bacterial AgentsAntibodies, BacterialRoxithromycinAzithromycin
Year: 2002 PMID： 12417534 DOI： 10.1161/01.cir.0000040403.57597.48
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690